| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000019931 |
| Receipt No. | R000023010 |
| Scientific Title | Safety and efficacy of the transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: A radial ultrasound follow-up study |
| Date of disclosure of the study information | 2015/12/01 |
| Last modified on | 2019/12/18 (Ver. 10) |
| Basic information | ||
| Public title | Safety and efficacy of the transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: A radial ultrasound follow-up study | |
| Acronym | Safety and efficacy of the sheathless transradial percutaneous coronary intervention for acute coronary syndrome | |
| Scientific Title | Safety and efficacy of the transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: A radial ultrasound follow-up study | |
| Scientific Title:Acronym | Safety and efficacy of the sheathless transradial percutaneous coronary intervention for acute coronary syndrome | |
| Region |
|
|
| Condition | ||
| Condition | Acute coronary syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Feasibility of the sheathless transradial percutaneous coronary intervention (PCI) in patients with acute coronary syndrome |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (1) Initial success of the procedure
(2) Coronary ostial dissection (3) Access-site complications at 1- or 2-day follow-up, including radial artery occlusion, arteriovenous fistula, local infection, pseudoaneurysm, radial access site bleeding and critical upper limb ischemia |
| Key secondary outcomes | (1) Access-site complications at 30-day follow-up
(2) Major adverse cardiac events at 30-, 180-day and 1-year follow-up, including all-cause death, myocardial infarction, stent thrombosis and target lesion revascularization |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients who suffered acute coronary syndrome and underwent ad hoc PCI via radial artery
(2) Ad hoc PCI was done using a 6.5-Fr or 7.5-Fr sheathless guiding catheter (Sheathless Eaucath; Asahi Intecc). (1) and (2) |
|||
| Key exclusion criteria | (1) The patients who underwent the procedure via femoral artery
(2) The patients who did not proceed to PCI (no coronary artery disease and patients advised for CABG) (1) or (2) |
|||
| Target sample size | 300 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Sendai Kousei Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | |||||||
| Address | 4-15, Hirose-machi, Sendai, 980-0873, Japan. | ||||||
| TEL | 81-22-222-6181 | ||||||
| kanametaki@hotmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Sendai Kousei Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | |||||||
| Address | 4-15, Hirose-machi, Sendai, 980-0873, Japan. | ||||||
| TEL | 81-22-222-6181 | ||||||
| Homepage URL | |||||||
| isa_tsuyo@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Sendai Kousei Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 仙台厚生病院(宮城県), Sendai Kousei Hospital (Miyagi prefecture, Japan) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | Cardiovasc Interv Ther. 2019 Dec 6. doi: 10.1007/s12928-019-00632-7. [Epub ahead of print] | ||||||
| Number of participants that the trial has enrolled | 500 | ||||||
| Results | |||||||
| Results date posted | |||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study design: observational study
Patient selection: Consecutive patients with acute coronary syndrome who visited our hospital and underwent transradial primary PCI from January 2015 were enrolled. Measurement: major caydiovascular event (All-cause death, myocardial infarction, stent thrombosis and target lesion revascularization), access-site complications, including radial artery occlusion |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023010 |